Cargando…
The COVID-19 pandemic: progress in nephrology
Patients with kidney disease are particularly vulnerable to COVID-19. In 2021, key studies demonstrated the safety of renin–angiotensin blockade in patients with kidney failure and COVID-19, and provided new data on the therapeutic potential of soluble angiotensin-converting enzyme, COVID-19 vaccine...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646337/ https://www.ncbi.nlm.nih.gov/pubmed/34873314 http://dx.doi.org/10.1038/s41581-021-00521-4 |
| _version_ | 1784610488058904576 |
|---|---|
| author | Soler, María José Jacobs-Cachá, Conxita |
| author_facet | Soler, María José Jacobs-Cachá, Conxita |
| author_sort | Soler, María José |
| collection | PubMed |
| description | Patients with kidney disease are particularly vulnerable to COVID-19. In 2021, key studies demonstrated the safety of renin–angiotensin blockade in patients with kidney failure and COVID-19, and provided new data on the therapeutic potential of soluble angiotensin-converting enzyme, COVID-19 vaccine responses and the long-term effects of COVID-19 on kidney function. |
| format | Online Article Text |
| id | pubmed-8646337 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86463372021-12-06 The COVID-19 pandemic: progress in nephrology Soler, María José Jacobs-Cachá, Conxita Nat Rev Nephrol Year in Review Patients with kidney disease are particularly vulnerable to COVID-19. In 2021, key studies demonstrated the safety of renin–angiotensin blockade in patients with kidney failure and COVID-19, and provided new data on the therapeutic potential of soluble angiotensin-converting enzyme, COVID-19 vaccine responses and the long-term effects of COVID-19 on kidney function. Nature Publishing Group UK 2021-12-06 2022 /pmc/articles/PMC8646337/ /pubmed/34873314 http://dx.doi.org/10.1038/s41581-021-00521-4 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Year in Review Soler, María José Jacobs-Cachá, Conxita The COVID-19 pandemic: progress in nephrology |
| title | The COVID-19 pandemic: progress in nephrology |
| title_full | The COVID-19 pandemic: progress in nephrology |
| title_fullStr | The COVID-19 pandemic: progress in nephrology |
| title_full_unstemmed | The COVID-19 pandemic: progress in nephrology |
| title_short | The COVID-19 pandemic: progress in nephrology |
| title_sort | covid-19 pandemic: progress in nephrology |
| topic | Year in Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646337/ https://www.ncbi.nlm.nih.gov/pubmed/34873314 http://dx.doi.org/10.1038/s41581-021-00521-4 |
| work_keys_str_mv | AT solermariajose thecovid19pandemicprogressinnephrology AT jacobscachaconxita thecovid19pandemicprogressinnephrology AT solermariajose covid19pandemicprogressinnephrology AT jacobscachaconxita covid19pandemicprogressinnephrology |